The 1984 Tasmanian insulin treated diabetes mellitus prevalence cohort: An eight and a half year mortality follow-up investigation

Riley, Malcolm; McCarty, Daniel J.; Couper, David J.; Humphrey, Alistair; Dwyer, Terence; Zimmet, Paul

doi:10.1016/0168-8227(95)01106-n

Cited by 16 publications

(16 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In New Zealand, Scragg (15) reported secular trends in mortality (1966)(1967)(1968)(1969)(1970)(1971)(1972)(1973)(1974)(1975)(1976)(1977)(1978)(1979)(1980)(1981)(1982)(1983)(1984)(1985), but no distinction was made for type of diabetes, and cases were enumerated through death certificates, which is problematic (16). The Tasmanian (Australian) Diabetes Registry mortality study (9) is the only other research undertaken in the region that is directly comparable to that reported here.…”

mentioning

confidence: 54%

“…In the absence of adequate biomarker data on a sufficient number of subjects, categorization was based on age at onset of diabetes and commencement of insulin therapy. This approach was also used by Riley et al (9). Group A comprised all subjects who had been diagnosed at age Ͻ30 years and who commenced insulin therapy within 12 months of diagnosis.…”

Section: Study Populationmentioning

confidence: 99%

“…Reflecting recent attempts at reclassification of diabetes (9,18,19), the study cohort was separated into three groups. In the absence of adequate biomarker data on a sufficient number of subjects, categorization was based on age at onset of diabetes and commencement of insulin therapy.…”

Section: Study Populationmentioning

confidence: 99%

“…espite improvements in the prognosis of individuals with diabetes (1-6), mortality is still two to four times higher for this population compared with general populations (7)(8)(9), with life expectancy reduced by up to one-third (5,10). This research is a prospective cohort study examining mortality in the Canterbury Diabetes Registry insulin-treated population (11,12).…”

mentioning

confidence: 99%

See 3 more Smart Citations

All-Cause Mortality in the Canterbury (New Zealand) Insulin-Treated Diabetic Registry Population

2001

View full text Add to dashboard Cite

RESEARCH DESIGN AND METHODS -Insulin-treated diabetic subjects (n = 1,008) on the Canterbury Diabetes Registry were tracked over 9 years, and their vital status was determined. Death rates were standardized using direct and indirect methods. Cox proportional hazard regression was used to model the effects of demographic and clinical covariates on survival time.RESULTS -At study entry, age ranged from 2.9 to 92.7 years, with mean 48.7 ± 20.4 years; age at diagnosis was 0.2-88.9 years, mean 34.5 ± 20.0 years; and duration of diabetes was 0.1-58.5 years, mean 14.0 ± 10.6 years. There were 303 deaths in 7,372 person-years of follow-up with a standardized mortality ratio (SMR) of 2.6 (95% CI 2.4-3.0). Relative mortality was greatest for those aged 30-39 years .2]). The death rate for the diabetic cohort standardized against the Segi world standard population was 16.2 per 1,000. Attained age, sex, and clinical subtype were significant predictors of mortality. The SMR for subjects with type 1 diabetes and age at onset Ͻ30 years was 3.7 (CI 2.7-5.0), 2.2 (1.8-2.6) for those with onset Ն30 years, and 3.1 (2.5-3.7) for subjects suspected of having latent autoimmune diabetes in adulthood or insulin-treated type 2 diabetes. Life expectancy was reduced for both sexes at all ages.CONCLUSIONS -Mortality rates for insulin-treated diabetic individuals remain high, resulting in shortened life spans relative to the general population. Marked differences in mortality exist between clinical groups of subjects. Further research is needed to improve diabetes classification and to clarify differences in health outcomes.

show abstract

mentioning

confidence: 54%

Section: Study Populationmentioning

confidence: 99%

Section: Study Populationmentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

All-Cause Mortality in the Canterbury (New Zealand) Insulin-Treated Diabetic Registry Population

2001

View full text Add to dashboard Cite

show abstract

“…Un tercer factor que puede influir es la edad y tiempo de evolución de la enfermedad de los pacientes de la cohorte, puesto que la SMR se atenúa con la edad y se agrava con la mayor duración (10,13,14). Finalmente el tipo de diabetes tiene gran importancia, ya que en estudios que dan resultados por separado para diabéticos tipo 1 y tipo 2, los tipo 1 tienen unas SMR más elevadas (12); no obstante las diferencias en este caso desaparecen si se comparan las SMR de diabéticos tipo 1 y diabéticos tipo 2 tratados con insulina , especialmente si los casos de diabetes tipo 1 han aparecido en la edad adulta (15,16).…”

Section: Discussionunclassified

Mortalidad en una cohorte de pacientes con diabetes tipo 2 del Área de Alcañiz

Orna

Juliani

Arnal

et al. 2002

An. Med. Interna (Madrid)

View full text Add to dashboard Cite

La diabetes mellitus está entre las 5 causas principales de mortalidad por enfermedad en la mayoría de los países (1). No obstante, las estadísticas infravaloran la contribución real de la diabetes a la mortalidad, porque el diagnóstico de diabetes se omite en muchas ocasiones en los certificados de defunción (2). Por ello los estudios de cohortes son el único modo satisfactorio de evaluar el riesgo de mortalidad entre pacientes con diabetes mellitus.Es un hecho ampliamente comprobado en la literatura que los sujetos con diabetes tienen mayor riesgo de mortalidad, [0212-7199(2002) 19: 7; pp 336-340] ANALES DE MEDICINA INTERNA

show abstract